EFFECT OF FOOD ON THE PHARMACOKINETICS OF CYCLOSPORINE IN HEALTHY-SUBJECTS FOLLOWING ORAL AND INTRAVENOUS ADMINISTRATION

被引:128
作者
GUPTA, SK
MANFRO, RC
TOMLANOVICH, SJ
GAMBERTOGLIO, JG
GAROVOY, MR
BENET, LZ
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT SURG,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143
关键词
D O I
10.1002/j.1552-4604.1990.tb01868.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of cyclosporine were studied in healthy subjects following administration of cyclosporine both orally (10 mg kg-1) and intravenously (4 mg kg-1) without and with high fat meals. Both blood and plasma samples (separated at 37°C) were analyzed for cyclosporins concentration. Blood and plasma clearances of cyclosporine were calculated to be 0.36 and 0.47 L hr-1 Kg-1, respectively, and volume of distribution at steady state was calculated to be 1.21 L Kg-1, when cyclosporine was administered without a high fat meal. Using plasma analysis, the oral bioavailability of cyclosporine was estimated to be 21 and 79%, when administered without and with a high fat meal, respectively. When cyclosporine was administered intravenously together with a high fat meal, both clearance and volume of distribution increased significantly. Blood and plasma clearances of cyclosporine were 0.44 and 0.70 L hr-1 Kg-1, respectively, when cyclosporine was administered along with a high fat meal. We conclude that food not only enhances the absorption of cyclosporine but also enhances its clearance and volume of distribution. The observed variability in clearance, bioavailability, and volume of distribution values for cyclosporine across various pharmacokinetic studies can be partially accounted by the type of food administered and the sampling matrix used for analysis.
引用
收藏
页码:643 / 653
页数:11
相关论文
共 26 条
[1]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[2]   EVALUATION OF CYCLOSPORIN PHENYTOIN INTERACTION WITH OBSERVATIONS ON CYCLOSPORIN METABOLITES [J].
FREEMAN, DJ ;
LAUPACIS, A ;
KEOWN, PA ;
STILLER, CR ;
CARRUTHERS, SG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (06) :887-893
[3]   PHARMACOKINETICS OF CYCLOSPORINE - INFLUENCE OF RATE-DURATION PROFILE OF AN INTRAVENOUS-INFUSION IN RENAL-TRANSPLANT PATIENTS [J].
GUPTA, SK ;
BAKRAN, A ;
JOHNSON, RWG ;
ROWLAND, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (03) :353-357
[4]   HPLC MEASUREMENT OF CYCLOSPORINE IN BLOOD-PLASMA AND URINE AND SIMULTANEOUS MEASUREMENT OF ITS 4 METABOLITES IN BLOOD [J].
GUPTA, SK ;
BENET, LZ .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1989, 12 (08) :1451-1462
[5]   HIGH-FAT MEALS INCREASE THE CLEARANCE OF CYCLOSPORINE [J].
GUPTA, SK ;
BENET, LZ .
PHARMACEUTICAL RESEARCH, 1990, 7 (01) :46-48
[6]   ABSORPTION KINETICS OF CYCLOSPORINE IN HEALTHY-VOLUNTEERS [J].
GUPTA, SK ;
BENET, LZ .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1989, 10 (06) :591-596
[7]   PHARMACOKINETICS OF CYCLOSPORINE - INFLUENCE OF RATE OF CONSTANT INTRAVENOUS-INFUSION IN RENAL-TRANSPLANT PATIENTS [J].
GUPTA, SK ;
LEGG, B ;
SOLOMON, LR ;
JOHNSON, RWG ;
ROWLAND, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (04) :519-526
[8]  
GUPTA SK, 1988, PHARMACEUT RES, V5, pS13
[9]  
KEOWN PA, 1983, TRANSPLANT P, V15, P2438
[10]  
KEOWN PA, 1982, TRANSPLANT P, V14, P659